迷走神经调控在炎症性肠病发病与治疗中的作用
本文为叙述性综述,总结自主神经系统与肠道炎症的关联及迷走神经调控的治疗潜力。临床与临床前证据显示迷走神经通过α7乙酰胆碱受体发挥全身和局部抗炎作用,IBD患者存在交感-迷走失衡,迷走神经调控可上调胆碱能抗炎通路,两项小型克罗恩病研究支持其作用,溃疡性结肠炎尚待研究。
要点
- 迷走神经通过乙酰胆碱激活α7乙酰胆碱受体,在全身和肠道局部发挥抗炎作用。
- IBD患者存在交感-迷走失衡、肠神经元功能性耗竭及HPA轴低反应性。
- 直接或经皮迷走神经调控可上调胆碱能抗炎通路,两项小型克罗恩病研究支持其作用。
核心结论
- 调节胆碱能抗炎通路可影响全身及肠道局部炎症,是一种可能未被充分利用的抗炎治疗策略。
- 鉴于自主神经系统在IBD中的潜在致病作用,迷走神经调控这一看似安全且成功提高迷走张力的方法值得进一步临床探索。
研究设计与样本
- 叙述性综述,对当前相关文献进行总结和批判性审视。
主要发现
- 大量临床前和临床证据表明迷走神经在全身和局部肠道水平具有多方面的抗炎效应。
- 迷走神经通过乙酰胆碱介导的α7乙酰胆碱受体激活发挥作用,涉及固有免疫和适应性免疫的多种细胞类型及肠神经系统,对肠道屏障、炎症机制和微生物组产生保护性影响。
- IBD患者存在交感-迷走失衡、功能性肠神经元耗竭和下丘脑-垂体-肾上腺轴低反应性的证据。
- 在临床前和临床模型中,直接或经皮迷走神经调控上调胆碱能抗炎通路,下调全身和局部肠道炎症。
- 两项小型克罗恩病研究支持上述作用,但在溃疡性结肠炎中仍有待研究。
临床怎么用
- 迷走神经调控可能作为一种抗炎治疗策略用于IBD,但尚需进一步临床探索。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There is a growing body of evidence implicating a role for the brain-gut axis in the pathogenesis of inflammation in patients with IBD. AIMS: To perform a narrative review of published literature regarding the association of the autonomic nervous system and intestinal inflammation and to describe the rationale for and emerging use of autonomic manipulation as a therapeutic agent METHODS: Current relevant literature was summarised and critically examined. RESULTS: There is substantial pre-clinical and clinical evidence for a multifaceted anti-inflammatory effect of the vagus at both systemic and local intestinal levels. It acts via acetylcholine-mediated activation of α-7-acetylcholine receptors involving multiple cell types in innate and adaptive immunity and the enteric nervous system with subsequent protective influences on the intestinal barrier, inflammatory mechanisms and the microbiome. In patients with IBD, there is evidence for a sympatho-vagal imbalance, functional enteric neuronal depletion and hyporeactivity of the hypothalamic-pituitary-adrenal axis. Direct or transcutaneous vagal neuromodulation up-regulates the cholinergic anti-inflammatory pathway in pre-clinical and clinical models with down-regulation of systemic and local intestinal inflammation. This is supported by two small studies in Crohn's disease although remains to be investigated in ulcerative colitis. CONCLUSIONS: Modulating the cholinergic anti-inflammatory pathway influences inflammation both systemically and at a local intestinal level. It represents a potentially underutilised anti-inflammatory therapeutic strategy. Given the likely pathogenic role of the autonomic nervous system in patients with IBD, vagal neuromodulation, an apparently safe and successful means of increasing vagal tone, warrants further clinical exploration.
引用
- Mogilevski T, Burgell R, Aziz Q, et al. Review article: the role of the autonomic nervous system in the pathogenesis and therapy of IBD. Aliment Pharmacol Ther. 2019. PMID: 31418887. doi:10.1111/apt.15433
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。